Dose Escalation Study of Immunomodulatory Nanoparticles
NCT04751786
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
PRECIOUS-01
Sponsor
Radboud University Medical Center
Collaborators
[object Object]